PD30-03 PREDICTING RESPONSE TO INTRAVESICAL BCG IN HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER USING AN ARTIFICIAL INTELLIGENCE-POWERED PATHOLOGY ASSAY: DEVELOPMENT AND VALIDATION IN AN INTERNATIONAL 12 CENTER COHORT.

Authors :: Lotan, Yair
Krishna, Viswesh
Launer, Bryn
Krishna, Vrishab
Singhi, Siddhant
Gordetsky, Jennifer
Shah, Jay B.
Gerald, Thomas
Shkolyar, Eugene
Hayne, Dickon
Redfern, Andrew
Spalding, Lisa
Stewart, Courtney
Narayan, Vikram
Patil, Dattatraya
Packiam, Vignesh T.
Rajan, Anand
O'Donnell, Michael A.
Baekelandt, Loic
Fernandez, Mario I.
Source :: Journal of Urology; 2024 Supplement 5, Vol. 211, pe625-e625, 1p
Publication Year :: 2024

Subjects :: BLADDER cancer
NON-muscle invasive bladder cancer
BCG immunotherapy
TRANSURETHRAL resection of bladder

Full Text Access

Tools